OpenURL Connection Search

Select item for more details and to access through your institution.

Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software.
Published in:
European Radiology, 2023, v. 33, n. 12, p. 8999, doi. 10.1007/s00330-023-09798-4
By:
- Orcel, T.;
- Chau, H. T.;
- Turlin, B.;
- Chaigneau, J.;
- Bannier, E.;
- Otal, P.;
- Frampas, E.;
- Leguen, A.;
- Boulic, A.;
- Saint-Jalmes, H.;
- Aubé, C.;
- Boursier, J.;
- Bardou-Jacquet, E.;
- Gandon, Y.
Publication type:
Article
Poor symptomatic relief and quality of life in patients treated for “solitary rectal ulcer syndrome without external rectal prolapse”.
Published in:
International Journal of Colorectal Disease, 2008, v. 23, n. 5, p. 521, doi. 10.1007/s00384-008-0445-9
By:
- Meurette, G.;
- Siproudhis, L.;
- Regenet, N.;
- Frampas, E.;
- Proux, M.;
- Lehur, P. A.
Publication type:
Article
An exceptional post-traumatic double hernia.
Published in:
2013
By:
- Armstrong, O.;
- Frampas, E.
Publication type:
Letter
Minimally invasive ventral mesh rectopexy for complex rectocoele: impact on anorectal and sexual function.
Published in:
Colorectal Disease, 2011, v. 13, n. 10, p. e320, doi. 10.1111/j.1463-1318.2011.02688.x
By:
- Wong, M. T. C.;
- Abet, E.;
- Rigaud, J.;
- Frampas, E.;
- Lehur, P. A.;
- Meurette, G.
Publication type:
Article
Anatomical and functional results after stapled transanal rectal resection (STARR) for obstructed defaecation syndrome.
Published in:
Colorectal Disease, 2011, v. 13, n. 1, p. e6, doi. 10.1111/j.1463-1318.2010.02415.x
By:
- Meurette, G.;
- Wong, M.;
- Frampas, E.;
- Regenet, N.;
- Lehur, P. A.
Publication type:
Article
Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study. .
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.252791
By:
- Bodet-Milin, C.;
- Faivre-Chauvet, A.;
- Carlier, T.;
- Ansquer, C.;
- Rauscher, A.;
- Frampas, E.;
- Toulgoat, F.;
- Masson, D.;
- Bourgeois, M.;
- Cerato, E.;
- Rohmer, V.;
- Couturier, O.;
- Drui, D.;
- Goldenberg, D. M.;
- Sharkey, R. M.;
- Barbet, J.;
- Kraeber-Bodere, F.
Publication type:
Article
Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post-hoc analysis of the iPET-MTC study.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.252791
By:
- Bodet-Milin, C.;
- Faivre-Chauvet, A.;
- Carlier, T.;
- Ansquer, C.;
- Rauscher, A.;
- Frampas, E.;
- Toulgoat, F.;
- Masson, D.;
- Bourgeois, M.;
- Cerato, E.;
- Rohmer, V.;
- Couturier, O.;
- Drui, D.;
- Goldenberg, D. M.;
- Sharkey, R. M.;
- Barbet, J.;
- Kraeber-Bodere, F.
Publication type:
Article
Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.252791
By:
- Bodet-Milin, C.;
- Faivre-Chauvet, A.;
- Carlier, T.;
- Ansquer, C.;
- Rauscher, A.;
- Frampas, E.;
- Toulgoat, F.;
- Masson, D.;
- Bourgeois, M.;
- Cerato, E.;
- Rohmer, V.;
- Couturier, O.;
- Drui, D.;
- Goldenberg, D. M.;
- Sharkey, R. M.;
- Barbet, J.;
- Kraeber-Bodere, F.
Publication type:
Article
Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 37, doi. 10.2967/jnumed.120.252791
By:
- Bodet-Milin, C.;
- Faivre-Chauvet, A.;
- Carlier, T.;
- Ansquer, C.;
- Rauscher, A.;
- Frampas, E.;
- Toulgoat, F.;
- Masson, D.;
- Bourgeois, M.;
- Cerato, E.;
- Rohmer, V.;
- Couturier, O.;
- Drui, D.;
- Goldenberg, D. M.;
- Sharkey, R. M.;
- Barbet, J.;
- Kraeber-Bodere, F.
Publication type:
Article
Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post-hoc analysis of the iPET-MTC study.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.252791
By:
- Bodet-Milin, C.;
- Faivre-Chauvet, A.;
- Carlier, T.;
- Ansquer, C.;
- Rauscher, A.;
- Frampas, E.;
- Toulgoat, F.;
- Masson, D.;
- Bourgeois, M.;
- Cerato, E.;
- Rohmer, V.;
- Couturier, O.;
- Drui, D.;
- Goldenberg, D. M.;
- Sharkey, R. M.;
- Barbet, J.;
- Kraeber-Bodere, F.
Publication type:
Article
Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post-hoc analysis of the iPET-MTC study.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.252791
By:
- Bodet-Milin, C.;
- Faivre-Chauvet, A.;
- Carlier, T.;
- Ansquer, C.;
- Rauscher, A.;
- Frampas, E.;
- Toulgoat, F.;
- Masson, D.;
- Bourgeois, M.;
- Cerato, E.;
- Rohmer, V.;
- Couturier, O.;
- Drui, D.;
- Goldenberg, D. M.;
- Sharkey, R. M.;
- Barbet, J.;
- Kraeber-Bodere, F.
Publication type:
Article
Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma.
Published in:
2010
By:
- Salaun PY;
- Bodet-Milin C;
- Frampas E;
- Oudoux A;
- Saï-Maurel C;
- Faivre-Chauvet A;
- Barbet J;
- Paris F;
- Kraeber-Bodéré F
Publication type:
Journal Article
Multi detector computed tomography (MDCT) for the diagnosis of early complications after pancreas transplantation.
Published in:
Abdominal Imaging, 2014, v. 39, n. 6, p. 1186, doi. 10.1007/s00261-014-0164-3
By:
- Vincent, M.;
- Morla, O.;
- Branchereau, J.;
- Karam, G.;
- Dupas, B.;
- Frampas, E.
Publication type:
Article
FDG-PET in Follicular Lymphoma Management.
Published in:
Journal of Oncology, 2012, p. 1, doi. 10.1155/2012/370272
By:
- Bodet-Milin, C.;
- Eugène, T.;
- Gastinne, T.;
- Frampas, E.;
- Le Gouill, S.;
- Kraeber-Bodéré, F.
Publication type:
Article
Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 3, p. 874, doi. 10.1007/s00259-020-04989-3
By:
- Touchefeu, Y.;
- Bailly, C.;
- Frampas, E.;
- Eugène, T.;
- Rousseau, C.;
- Bourgeois, M.;
- Bossard, C.;
- Faivre-Chauvet, A.;
- Rauscher, A.;
- Masson, D.;
- David, A.;
- Cerato, E.;
- Carlier, T.;
- Sharkey, R. M.;
- Goldenberg, D. M.;
- Barbet, J.;
- Kraeber-Bodere, F.;
- Bodet-Milin, C.
Publication type:
Article

Found: 15